2023 Q4 Form 20-F Financial Statement

#000149315224012556 Filed on April 02, 2024

View on sec.gov

Income Statement

Concept 2023 Q4 2023 2022 Q4
Revenue $246.6K
YoY Change 26.0%
Cost Of Revenue $179.9K
YoY Change 25.91%
Gross Profit $66.68K
YoY Change 26.22%
Gross Profit Margin 27.04%
Selling, General & Admin $316.0K
YoY Change -1.44%
% of Gross Profit 473.91%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization $0.00
YoY Change -100.0%
% of Gross Profit 0.0%
Operating Expenses $316.0K
YoY Change -4.69%
Operating Profit -$249.3K
YoY Change -10.55%
Interest Expense $24.00
YoY Change -60.66%
% of Operating Profit
Other Income/Expense, Net -$684.00
YoY Change -63.09%
Pretax Income -$250.0K
YoY Change -10.88%
Income Tax
% Of Pretax Income
Net Earnings -$250.0K
YoY Change -10.88%
Net Earnings / Revenue -101.37%
Basic Earnings Per Share -$0.01
Diluted Earnings Per Share -$0.01
COMMON SHARES
Basic Shares Outstanding 45.00M shares 45.00M shares 45.00M shares
Diluted Shares Outstanding 45.00M shares

Balance Sheet

Concept 2023 Q4 2023 2022 Q4
SHORT-TERM ASSETS
Cash & Short-Term Investments
YoY Change
Cash & Equivalents $3.058K $15.01K
Short-Term Investments
Other Short-Term Assets
YoY Change
Inventory
Prepaid Expenses $170.9K $58.24K
Receivables $2.618K
Other Receivables $635.00 $1.461K
Total Short-Term Assets $177.2K $74.70K
YoY Change 137.25% 19.76%
LONG-TERM ASSETS
Property, Plant & Equipment
YoY Change
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets
YoY Change
Total Long-Term Assets $0.00 $0.00
YoY Change -100.0%
TOTAL ASSETS
Total Short-Term Assets $177.2K $74.70K
Total Long-Term Assets $0.00 $0.00
Total Assets $177.2K $74.70K
YoY Change 137.25% -4.8%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $83.00
YoY Change
Accrued Expenses
YoY Change
Deferred Revenue
YoY Change
Short-Term Debt
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $382.2K
YoY Change -40.5%
LONG-TERM LIABILITIES
Long-Term Debt
YoY Change
Other Long-Term Liabilities
YoY Change
Total Long-Term Liabilities
YoY Change
TOTAL LIABILITIES
Total Short-Term Liabilities $382.2K
Total Long-Term Liabilities
Total Liabilities $721.2K $382.2K
YoY Change 88.7% -41.2%
SHAREHOLDERS EQUITY
Retained Earnings -$1.064M -$814.3K
YoY Change 30.7% 52.55%
Common Stock $0.00 $0.00
YoY Change
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity -$544.0K -$307.5K
YoY Change
Total Liabilities & Shareholders Equity $177.2K $74.70K
YoY Change 137.25% -4.8%

Cashflow Statement

Concept 2023 Q4 2023 2022 Q4
OPERATING ACTIVITIES
Net Income -$250.0K
YoY Change -10.88%
Depreciation, Depletion And Amortization $0.00
YoY Change -100.0%
Cash From Operating Activities -$5.149K
YoY Change -96.46%
INVESTING ACTIVITIES
Capital Expenditures
YoY Change
Acquisitions
YoY Change
Other Investing Activities
YoY Change
Cash From Investing Activities
YoY Change
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities -$10.93K
YoY Change -106.85%
NET CHANGE
Cash From Operating Activities -$5.149K
Cash From Investing Activities
Cash From Financing Activities -$10.93K
Net Change In Cash -$11.95K
YoY Change -182.12%
FREE CASH FLOW
Cash From Operating Activities -$5.149K
Capital Expenditures
Free Cash Flow
YoY Change

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2023 dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
D8
CY2023 dei Amendment Flag
AmendmentFlag
false
CY2023 dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
FY
CY2023 dei Entity Central Index Key
EntityCentralIndexKey
0001941189
CY2022Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
usd
CY2023Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
usd
CY2023Q4 us-gaap Taxes Payable Current
TaxesPayableCurrent
usd
CY2022Q4 TANAF Shares To Be Issued
SharesToBeIssued
usd
CY2023Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
usd
CY2022Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
usd
CY2023Q4 us-gaap Common Stock Value
CommonStockValue
usd
CY2022Q4 us-gaap Common Stock Value
CommonStockValue
usd
CY2023 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
usd
CY2023 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
usd
CY2022 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
usd
CY2023 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
usd
CY2023 us-gaap Gain Loss On Disposition Of Assets1
GainLossOnDispositionOfAssets1
usd
CY2022 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
usd
CY2023 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
usd
CY2023 us-gaap Increase Decrease In Operating Lease Liability
IncreaseDecreaseInOperatingLeaseLiability
usd
CY2022 TANAF Proceeds From Shares To Be Issued
ProceedsFromSharesToBeIssued
usd
CY2023 us-gaap Proceeds From Contributed Capital
ProceedsFromContributedCapital
usd
CY2023 us-gaap Proceeds From Repayments Of Notes Payable
ProceedsFromRepaymentsOfNotesPayable
usd
CY2023 us-gaap Proceeds From Sale Of Productive Assets
ProceedsFromSaleOfProductiveAssets
usd
CY2023 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
usd
CY2023 us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
usd
CY2022 us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
usd
CY2023 TANAF Establishment Of Right Of Use Assets And Lease Liabilities For New Leases
EstablishmentOfRightOfUseAssetsAndLeaseLiabilitiesForNewLeases
usd
CY2022 TANAF Establishment Of Right Of Use Assets And Lease Liabilities For New Leases
EstablishmentOfRightOfUseAssetsAndLeaseLiabilitiesForNewLeases
usd
CY2023 TANAF Reduction Of Right Of Use Assets And Lease Liabilities For Cancelation Of Old Leases
ReductionOfRightOfUseAssetsAndLeaseLiabilitiesForCancelationOfOldLeases
usd
CY2023 us-gaap Operating Lease Cost
OperatingLeaseCost
usd
CY2023 us-gaap Variable Lease Cost
VariableLeaseCost
usd
CY2022 us-gaap Variable Lease Cost
VariableLeaseCost
usd
CY2023 us-gaap Increase Decrease In Operating Lease Liability
IncreaseDecreaseInOperatingLeaseLiability
usd
CY2023 us-gaap Right Of Use Asset Obtained In Exchange For Operating Lease Liability
RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
usd
CY2022 us-gaap Right Of Use Asset Obtained In Exchange For Operating Lease Liability
RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
usd
CY2023 TANAF Reduction Of Right Of Use Assets And Lease Liabilities For Cancelation Of Old Leases
ReductionOfRightOfUseAssetsAndLeaseLiabilitiesForCancelationOfOldLeases
usd
CY2023Q4 us-gaap Loans Payable
LoansPayable
usd
CY2022Q4 us-gaap Loans Payable
LoansPayable
usd
CY2023 us-gaap Income Tax Reconciliation Nondeductible Expense
IncomeTaxReconciliationNondeductibleExpense
usd
CY2022 us-gaap Income Tax Reconciliation Nondeductible Expense
IncomeTaxReconciliationNondeductibleExpense
usd
CY2023 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
usd
CY2022 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
usd
CY2023 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
usd
CY2023 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
usd
CY2023Q4 TANAF Unallocated Assets
UnallocatedAssets
usd
CY2022 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
usd
CY2022Q4 TANAF Unallocated Assets
UnallocatedAssets
usd
CY2023 dei Document Type
DocumentType
20-F
CY2023 dei Document Registration Statement
DocumentRegistrationStatement
false
CY2023 dei Document Annual Report
DocumentAnnualReport
true
CY2023 dei Document Period End Date
DocumentPeriodEndDate
2023-12-31
CY2023 dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
CY2023 dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2023
CY2023 dei Document Transition Report
DocumentTransitionReport
false
CY2023 dei Document Shell Company Report
DocumentShellCompanyReport
false
CY2023 dei Entity File Number
EntityFileNumber
333-267453
CY2023 dei Entity Registrant Name
EntityRegistrantName
TIAN’AN TECHNOLOGY GROUP LTD.
CY2023 dei Entity Address Address Line1
EntityAddressAddressLine1
Room 501
CY2023 dei Entity Address Address Line2
EntityAddressAddressLine2
No. 3, Lane 743
CY2023 dei Entity Address Address Line3
EntityAddressAddressLine3
Taopu Road, Putuo District
CY2023 dei Entity Address City Or Town
EntityAddressCityOrTown
Shanghai
CY2023 dei Entity Address Country
EntityAddressCountry
CN
CY2023 dei Security12b Title
Security12bTitle
Ordinary Shares
CY2023Q4 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
45000000 shares
CY2023 dei Entity Well Known Seasoned Issuer
EntityWellKnownSeasonedIssuer
No
CY2023 dei Entity Voluntary Filers
EntityVoluntaryFilers
No
CY2023 dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
CY2023 dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
CY2023 dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
CY2023 dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
true
CY2023 dei Entity Ex Transition Period
EntityExTransitionPeriod
false
CY2023 dei Document Accounting Standard
DocumentAccountingStandard
U.S. GAAP
CY2023 dei Document Fin Stmt Error Correction Flag
DocumentFinStmtErrorCorrectionFlag
false
CY2023 dei Entity Shell Company
EntityShellCompany
false
CY2023 dei Auditor Name
AuditorName
HHC
CY2023 dei Auditor Location
AuditorLocation
Forest Hills, New York
CY2023 dei Auditor Firm
AuditorFirmId
5867
CY2023Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
3058 usd
CY2022Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
15005 usd
CY2023Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
2618 usd
CY2023Q4 us-gaap Other Receivables Net Current
OtherReceivablesNetCurrent
635 usd
CY2022Q4 us-gaap Other Receivables Net Current
OtherReceivablesNetCurrent
1461 usd
CY2023Q4 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
170922 usd
CY2022Q4 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
58236 usd
CY2023Q4 us-gaap Assets Current
AssetsCurrent
177233 usd
CY2022Q4 us-gaap Assets Current
AssetsCurrent
74702 usd
CY2022Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
83 usd
CY2023Q4 us-gaap Accrued Payroll Taxes Current
AccruedPayrollTaxesCurrent
7874 usd
CY2022Q4 us-gaap Accrued Payroll Taxes Current
AccruedPayrollTaxesCurrent
8002 usd
CY2022Q4 us-gaap Taxes Payable Current
TaxesPayableCurrent
1570 usd
CY2023Q4 us-gaap Other Notes Payable Current
OtherNotesPayableCurrent
110298 usd
CY2022Q4 us-gaap Other Notes Payable Current
OtherNotesPayableCurrent
124986 usd
CY2023Q4 TANAF Shares To Be Issued
SharesToBeIssued
107200 usd
CY2023Q4 us-gaap Liabilities
Liabilities
721197 usd
CY2022Q4 us-gaap Liabilities
Liabilities
382201 usd
CY2023Q4 us-gaap Common Stock No Par Value
CommonStockNoParValue
0
CY2022Q4 us-gaap Common Stock No Par Value
CommonStockNoParValue
0
CY2023Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
100000000 shares
CY2022Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
100000000 shares
CY2023Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
45000000 shares
CY2023Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
45000000 shares
CY2022Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
45000000 shares
CY2022Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
45000000 shares
CY2023Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
500000 usd
CY2022Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
500000 usd
CY2023Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-1064348 usd
CY2022Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-814339 usd
CY2023Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
20384 usd
CY2022Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
6840 usd
CY2023Q4 us-gaap Stockholders Equity
StockholdersEquity
-543964 usd
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
-307499 usd
CY2023Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
177233 usd
CY2022Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
74702 usd
CY2023 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
246619 usd
CY2022 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
195733 usd
CY2023 us-gaap Cost Of Revenue
CostOfRevenue
179938 usd
CY2022 us-gaap Cost Of Revenue
CostOfRevenue
142905 usd
CY2023 us-gaap Gross Profit
GrossProfit
66681 usd
CY2022 us-gaap Gross Profit
GrossProfit
52828 usd
CY2022 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
10945 usd
CY2023 us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
40225 usd
CY2022 us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
12917 usd
CY2023 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
275781 usd
CY2022 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
307691 usd
CY2022 us-gaap Increase Decrease In Operating Lease Liability
IncreaseDecreaseInOperatingLeaseLiability
-4461 usd
CY2023 us-gaap Increase Decrease In Other Operating Liabilities
IncreaseDecreaseInOtherOperatingLiabilities
-11526 usd
CY2022 us-gaap Increase Decrease In Other Operating Liabilities
IncreaseDecreaseInOtherOperatingLiabilities
128065 usd
CY2023 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-5149 usd
CY2023 us-gaap Operating Expenses
OperatingExpenses
316006 usd
CY2022 us-gaap Operating Expenses
OperatingExpenses
331553 usd
CY2023 us-gaap Operating Income Loss
OperatingIncomeLoss
-249325 usd
CY2022 us-gaap Operating Income Loss
OperatingIncomeLoss
-278725 usd
CY2023 us-gaap Interest Income Expense Nonoperating Net
InterestIncomeExpenseNonoperatingNet
24 usd
CY2022 us-gaap Interest Income Expense Nonoperating Net
InterestIncomeExpenseNonoperatingNet
61 usd
CY2023 us-gaap Other Nonoperating Expense
OtherNonoperatingExpense
708 usd
CY2022 us-gaap Other Nonoperating Expense
OtherNonoperatingExpense
1853 usd
CY2023 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-684 usd
CY2022 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-1792 usd
CY2023 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-250009 usd
CY2022 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-280517 usd
CY2023 us-gaap Net Income Loss
NetIncomeLoss
-250009 usd
CY2022 us-gaap Net Income Loss
NetIncomeLoss
-280517 usd
CY2023 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
13544 usd
CY2022 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
44546 usd
CY2023 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-236465 usd
CY2022 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-235971 usd
CY2023 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.01
CY2023 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.01
CY2022 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.01
CY2022 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.01
CY2023 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
45000000 shares
CY2023 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
45000000 shares
CY2022 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
41821918 shares
CY2022 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
41821918 shares
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
-571528 usd
CY2022 us-gaap Net Income Loss
NetIncomeLoss
-280517 usd
CY2022 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
500000 usd
CY2022 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
44546 usd
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
-307499 usd
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
-307499 usd
CY2023 us-gaap Net Income Loss
NetIncomeLoss
-250009 usd
CY2023 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
13544 usd
CY2023Q4 us-gaap Stockholders Equity
StockholdersEquity
-543964 usd
CY2023Q4 us-gaap Stockholders Equity
StockholdersEquity
-543964 usd
CY2023 us-gaap Net Income Loss
NetIncomeLoss
-250009 usd
CY2022 us-gaap Net Income Loss
NetIncomeLoss
-280517 usd
CY2022 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
5470 usd
CY2022 us-gaap Gain Loss On Disposition Of Assets1
GainLossOnDispositionOfAssets1
-978 usd
CY2023 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
2639 usd
CY2023 us-gaap Increase Decrease In Other Receivables
IncreaseDecreaseInOtherReceivables
-794 usd
CY2022 us-gaap Increase Decrease In Other Receivables
IncreaseDecreaseInOtherReceivables
-480 usd
CY2022 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
-30209 usd
CY2023 us-gaap Increase Decrease In Due To Related Parties Current
IncreaseDecreaseInDueToRelatedPartiesCurrent
-115124 usd
CY2022 us-gaap Increase Decrease In Due To Related Parties Current
IncreaseDecreaseInDueToRelatedPartiesCurrent
-44320 usd
CY2023 us-gaap Increase Decrease In Accounts Payable Trade
IncreaseDecreaseInAccountsPayableTrade
-82 usd
CY2022 us-gaap Increase Decrease In Accounts Payable Trade
IncreaseDecreaseInAccountsPayableTrade
85 usd
CY2023 us-gaap Increase Decrease In Due From Related Parties Current
IncreaseDecreaseInDueFromRelatedPartiesCurrent
-374898 usd
CY2022 us-gaap Increase Decrease In Due From Related Parties Current
IncreaseDecreaseInDueFromRelatedPartiesCurrent
-27739 usd
CY2023 us-gaap Increase Decrease In Employee Related Liabilities
IncreaseDecreaseInEmployeeRelatedLiabilities
81 usd
CY2022 us-gaap Increase Decrease In Employee Related Liabilities
IncreaseDecreaseInEmployeeRelatedLiabilities
-21691 usd
CY2023 us-gaap Increase Decrease In Accrued Income Taxes Payable
IncreaseDecreaseInAccruedIncomeTaxesPayable
-1542 usd
CY2022 us-gaap Increase Decrease In Accrued Income Taxes Payable
IncreaseDecreaseInAccruedIncomeTaxesPayable
12544 usd
CY2022 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-145419 usd
CY2023 TANAF Proceeds From Shares To Be Issued
ProceedsFromSharesToBeIssued
107200 usd
CY2022 us-gaap Proceeds From Contributed Capital
ProceedsFromContributedCapital
505121 usd
CY2023 us-gaap Proceeds From Repayments Of Related Party Debt
ProceedsFromRepaymentsOfRelatedPartyDebt
130943 usd
CY2022 us-gaap Proceeds From Repayments Of Related Party Debt
ProceedsFromRepaymentsOfRelatedPartyDebt
312367 usd
CY2023 us-gaap Repayments Of Related Party Debt
RepaymentsOfRelatedPartyDebt
249076 usd
CY2022 us-gaap Repayments Of Related Party Debt
RepaymentsOfRelatedPartyDebt
553810 usd
CY2022 us-gaap Proceeds From Repayments Of Notes Payable
ProceedsFromRepaymentsOfNotesPayable
-103974 usd
CY2023 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-10933 usd
CY2022 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
159704 usd
CY2022 us-gaap Proceeds From Sale Of Productive Assets
ProceedsFromSaleOfProductiveAssets
163 usd
CY2022 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
163 usd
CY2023 us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
4135 usd
CY2022 us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
101 usd
CY2023 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-11947 usd
CY2022 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
14549 usd
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
15005 usd
CY2021Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
456 usd
CY2023Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
3058 usd
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
15005 usd
CY2023 us-gaap Interest Paid Net
InterestPaidNet
24 usd
CY2022 us-gaap Interest Paid Net
InterestPaidNet
61 usd
CY2022 TANAF Reduction Of Right Of Use Assets And Lease Liabilities For Cancelation Of Old Leases
ReductionOfRightOfUseAssetsAndLeaseLiabilitiesForCancelationOfOldLeases
9048 usd
CY2023 us-gaap Use Of Estimates
UseOfEstimates
<p id="xdx_846_eus-gaap--UseOfEstimates_zjSdiTq3H1xb" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_869_zIEQGIWdY0u2">Use of Estimates and Assumptions</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The preparation of financial statements in conformity with US GAAP requires Management to make estimates and judgments that affect the reported amounts of assets and liabilities, disclosure of contingent assets and liabilities on the date of the financial statements, and the reported amounts of revenues and expenses during the reporting period.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Management bases its estimates and judgments on historical experience and on various other assumptions and information that are believed to be reasonable under the circumstances. Estimates and assumptions of future events and their effects cannot be perceived with certainty and, accordingly, these estimates may change as new events occur, as more experience is acquired, as additional information is obtained, and as the Company’s operating environment changes. Significant estimates and assumptions by Management include, among others, useful life and impairment analysis of long-lived assets, valuation of inventory and right-of-use assets and liabilities, allowance for credit loss of financial assets, other receivables and prepayments. While Management believes that the estimates and assumptions used in the preparation of the financial statements are appropriate, actual results could differ from those estimates. Estimates and assumptions are periodically reviewed and the effects of revisions are reflected in the financial statements in the period they are determined to be necessary.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p>
CY2023 us-gaap Concentration Risk Credit Risk
ConcentrationRiskCreditRisk
<p id="xdx_84D_eus-gaap--ConcentrationRiskCreditRisk_zMmxz6g4yAP8" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_86D_zghTv1j82XHe">Concentrations of Business and Credit Risks</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">All of the Company’s manufacturing is located in the PRC. There can be no assurance that the Company will be able to successfully continue to manufacture its products and failure to do so would have a material adverse effect on the Company’s financial position, results of operations and cash flows. Moreover, the success of the Company’s operations is subject to numerous contingencies, some of which are beyond management’s control. These contingencies include general economic conditions, prices of raw materials, competition, governmental and political conditions, and changes in regulations. Since the Company is dependent on trade in the PRC, the Company is subject to various additional political, economic and other uncertainties. Among other risks, the Company’s operations will be subject to the risks of restrictions on transfer of funds, domestic customs, changing taxation policies, foreign exchange restrictions, and political and governmental regulations. The Company operates in China, which may give rise to significant foreign currency risks from fluctuations and the degree of volatility of foreign exchange rates between United States dollars (“USD”) and the Chinese currency Renminbi (“RMB”). The results of operations denominated in foreign currency are translated at the average rate of exchange during the reporting periods.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p>
CY2023Q4 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
170922 usd
CY2022Q4 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
58236 usd
CY2023 us-gaap Other Comprehensive Income Loss Foreign Currency Translation Adjustment Tax
OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax
13544 usd
CY2023 us-gaap Income Tax Examination Description
IncomeTaxExaminationDescription
greater than 50% likelihood
CY2022 us-gaap Other Comprehensive Income Loss Foreign Currency Translation Adjustment Tax
OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax
44546 usd
CY2023 us-gaap Number Of Reportable Segments
NumberOfReportableSegments
1 segments
CY2022 us-gaap Number Of Reportable Segments
NumberOfReportableSegments
2 segments
CY2023Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-1064348 usd
CY2023Q4 TANAF Working Capital
WorkingCapital
-543964 usd
CY2022Q4 us-gaap Property Plant And Equipment Disposals
PropertyPlantAndEquipmentDisposals
163 usd
CY2022Q4 us-gaap Gain Loss On Disposition Of Assets
GainLossOnDispositionOfAssets
-978 usd
CY2022Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
0 usd
CY2023 us-gaap Depreciation
Depreciation
0 usd
CY2022 us-gaap Depreciation
Depreciation
1009 usd
CY2023 us-gaap Lessee Operating Lease Description
LesseeOperatingLeaseDescription
April 17, 2021 to April 16, 2024
CY2022 us-gaap Operating Lease Cost
OperatingLeaseCost
4461 usd
CY2023 us-gaap Short Term Lease Cost
ShortTermLeaseCost
7686 usd
CY2022 us-gaap Short Term Lease Cost
ShortTermLeaseCost
2005 usd
CY2023 us-gaap Lease Cost
LeaseCost
7686 usd
CY2022 us-gaap Lease Cost
LeaseCost
6466 usd
CY2022 us-gaap Increase Decrease In Operating Lease Liability
IncreaseDecreaseInOperatingLeaseLiability
-4461 usd
CY2022 TANAF Reduction Of Right Of Use Assets And Lease Liabilities For Cancelation Of Old Leases
ReductionOfRightOfUseAssetsAndLeaseLiabilitiesForCancelationOfOldLeases
9048 usd
CY2022Q4 us-gaap Debt Instrument Interest Rate Stated Percentage
DebtInstrumentInterestRateStatedPercentage
0.0003 pure
CY2023Q4 us-gaap Other Notes Payable Current
OtherNotesPayableCurrent
110298 usd
CY2022Q4 us-gaap Other Notes Payable Current
OtherNotesPayableCurrent
124986 usd
CY2023Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
100000000 shares
CY2023Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
45000000 shares
CY2022Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
45000000 shares
CY2022Q3 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
100000000 shares
CY2022Q3 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
40000000 shares
CY2023 us-gaap Effective Income Tax Rate Reconciliation Tax Exempt Income
EffectiveIncomeTaxRateReconciliationTaxExemptIncome
0.165 pure
CY2023 us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.25 pure
CY2023 us-gaap Foreign Income Tax Expense Benefit Continuing Operations
ForeignIncomeTaxExpenseBenefitContinuingOperations
-250009 usd
CY2022 us-gaap Foreign Income Tax Expense Benefit Continuing Operations
ForeignIncomeTaxExpenseBenefitContinuingOperations
-280517 usd
CY2023 us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.25 pure
CY2022 us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.25 pure
CY2023 us-gaap Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate
IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate
-62502 usd
CY2022 us-gaap Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate
IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate
-70129 usd
CY2023 us-gaap Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance
IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance
62502 usd
CY2022 us-gaap Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance
IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance
70129 usd
CY2023 us-gaap Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance
IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance
62502 usd
CY2022 us-gaap Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance
IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance
70129 usd
CY2023Q4 TANAF Value Added Tax Percentage
ValueAddedTaxPercentage
0.13 pure
CY2023Q4 us-gaap Value Added Tax Receivable
ValueAddedTaxReceivable
1500 usd
CY2022Q4 us-gaap Value Added Tax Receivable
ValueAddedTaxReceivable
1570 usd
CY2023Q4 TANAF Income Tax Expenses Related To Other Levies And Withholding
IncomeTaxExpensesRelatedToOtherLeviesAndWithholding
0 usd
CY2022Q4 TANAF Income Tax Expenses Related To Other Levies And Withholding
IncomeTaxExpensesRelatedToOtherLeviesAndWithholding
0 usd
CY2023 us-gaap Net Income Loss
NetIncomeLoss
-250009 usd
CY2022 us-gaap Net Income Loss
NetIncomeLoss
-280517 usd
CY2023 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
45000000 shares
CY2023 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
45000000 shares
CY2022 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
41821918 shares
CY2022 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
41821918 shares
CY2023 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.01
CY2023 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.01
CY2022 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.01
CY2022 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.01
CY2023 us-gaap Statutory Accounting Practices Statutory Capital And Surplus Variations
StatutoryAccountingPracticesStatutoryCapitalAndSurplusVariations
Appropriation to the statutory reserve should be at least 10% of the after-tax net income until the reserve is equal to 50% of the registered capital.
CY2023Q4 TANAF Statutory Reserves
StatutoryReserves
0 usd
CY2022Q4 TANAF Statutory Reserves
StatutoryReserves
0 usd
CY2022 us-gaap Number Of Reportable Segments
NumberOfReportableSegments
2 segments
CY2023 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
246619 usd
CY2023 us-gaap Cost Of Revenue
CostOfRevenue
179938 usd
CY2023 us-gaap Gross Profit
GrossProfit
66681 usd
CY2023 us-gaap Operating Income Loss
OperatingIncomeLoss
-249325 usd
CY2023Q4 us-gaap Assets
Assets
177233 usd
CY2023 TANAF Other Nonoperating Income Loss
OtherNonoperatingIncomeLoss
-684 usd
CY2023 us-gaap Net Income Loss
NetIncomeLoss
-250009 usd
CY2023Q4 us-gaap Assets
Assets
177233 usd
CY2022 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
195733 usd
CY2022 us-gaap Cost Of Revenue
CostOfRevenue
142905 usd
CY2022 us-gaap Gross Profit
GrossProfit
52828 usd
CY2022 us-gaap Operating Income Loss
OperatingIncomeLoss
-278725 usd
CY2022 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
5470 usd
CY2022Q4 us-gaap Assets
Assets
74702 usd
CY2022 TANAF Other Nonoperating Income Loss
OtherNonoperatingIncomeLoss
-1792 usd
CY2022 us-gaap Net Income Loss
NetIncomeLoss
-280517 usd
CY2022Q4 us-gaap Assets
Assets
74702 usd
CY2023Q4 TANAF Cash On Hand And Deposits Percentage
CashOnHandAndDepositsPercentage
1 pure
CY2022Q4 TANAF Cash On Hand And Deposits Percentage
CashOnHandAndDepositsPercentage
1 pure

Files In Submission

Name View Source Status
0001493152-24-012556-index-headers.html Edgar Link pending
0001493152-24-012556-index.html Edgar Link pending
0001493152-24-012556.txt Edgar Link pending
0001493152-24-012556-xbrl.zip Edgar Link pending
audit_001.jpg Edgar Link pending
ex10-10.htm Edgar Link pending
ex10-11.htm Edgar Link pending
ex10-11_001.jpg Edgar Link pending
ex10-11_002.jpg Edgar Link pending
ex10-11_003.jpg Edgar Link pending
ex10-11_004.jpg Edgar Link pending
ex10-11_005.jpg Edgar Link pending
ex10-9.htm Edgar Link pending
ex14-1.htm Edgar Link pending
ex21-1.htm Edgar Link pending
ex31-1.htm Edgar Link pending
ex31-2.htm Edgar Link pending
ex32-1.htm Edgar Link pending
ex32-2.htm Edgar Link pending
Financial_Report.xlsx Edgar Link pending
form20-f.htm Edgar Link pending
form20-f_001.jpg Edgar Link pending
form20-f_002.jpg Edgar Link pending
form20-f_003.jpg Edgar Link pending
form20-f_004.jpg Edgar Link pending
form20-f_005.jpg Edgar Link pending
form20-f_006.jpg Edgar Link pending
form20-f_007.jpg Edgar Link pending
form20-f_008.jpg Edgar Link pending
form20-f_009.jpg Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
tanaf-20231231.xsd Edgar Link pending
form20-f_htm.xml Edgar Link completed
tanaf-20231231_lab.xml Edgar Link unprocessable
tanaf-20231231_pre.xml Edgar Link unprocessable
tanaf-20231231_cal.xml Edgar Link unprocessable
tanaf-20231231_def.xml Edgar Link unprocessable